AstraZeneca-Daiichi Sankyo Enhertu gets two breakthrough therapy designations in US for multiple HER2 expressing cancers Ruchika Sharma3 Sept 2023 4:00 PM ISTTokyo: Daiichi Sankyo has announced that ENHERTU (fam-trastuzumab deruxtecan-nxki) has been granted two additional Breakthrough Therapy Designations...
AstraZeneca Soliris approved in Japan for paediatric patients with generalised myasthenia gravis Ruchika Sharma29 Aug 2023 4:14 PM ISTCambridge: AstraZeneca's Soliris (eculizumab) has been approved in Japan for expanded use to include the treatment of generalised myasthenia gravis...
AstraZeneca's Lynparza plus abiraterone approved in Japan for treatment of BRCA-mutated metastatic castration-resistant prostate cancer Ruchika Sharma26 Aug 2023 11:30 AM ISTCambridge: AstraZeneca and MSD’s Lynparza (olaparib) in combination with abiraterone and prednisolone has been approved in Japan for the treatment of...
AstraZeneca facing two London lawsuits over COVID vaccines Ruchika Sharma24 Aug 2023 11:37 AM ISTThe two cases are the first lawsuits brought in England and Wales over an adverse reaction to a COVID 19 vaccine, according to publicly available...
AstraZeneca Forxiga approved in China to reduce cardiovascular death, hospitalisation risk in adults with symptomatic chronic heart failure Ruchika Sharma20 Aug 2023 1:30 PM ISTForxiga is a first-in-class, oral, once-daily selective inhibitor of human sodium-glucose co-transporter 2 (SGLT2).
CDSCO Panel Approves AstraZeneca's Phase III CT proposal For COPD Drug Tozorakimab Dr. Divya Colin19 Aug 2023 6:00 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Sanofi-AstraZeneca Beyfortus gets unanimous US CDC Advisory Committee recommendation to prevent RSV in neonates, infants Ruchika Sharma4 Aug 2023 1:09 PM ISTParis: Sanofi has recently announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization...
AstraZeneca gets right to commercialize Eplontersen in Latin America Ruchika Sharma1 Aug 2023 1:30 PM ISTAstraZeneca paid Ionis USD 20 million to license eplontersen in Latin America.
AstraZeneca names Sharon Barr as Executive Vice President BioPharmaceuticals RnD Ruchika Sharma29 July 2023 11:38 AM ISTCambridge: AstraZeneca has announced the appointment of Sharon Barr as Executive Vice President, BioPharmaceuticals R&D. Sharon will succeed Mene...
AstraZeneca Soliris approved in EU for children, adolescents with refractory generalised myasthenia gravis Ruchika Sharma28 July 2023 2:30 PM ISTSoliris (eculizumab) is a first-in-class C5 complement inhibitor.
DCGI approves AstraZeneca Dapagliflozin for heart failure treatment in adults Ruchika Sharma25 July 2023 12:30 PM ISTNew Delhi: AstraZeneca Pharma India Ltd., a science-led biopharmaceutical company, announced it has received extended indication approval from the...
Sanofi-AstraZeneca Beyfortus gets USFDA nod for protection of infants against RSV disease Ruchika Sharma18 July 2023 11:24 AM ISTParis: The U.S. Food and Drug Administration (FDA) has approved Sanofi and AstraZeneca’s Beyfortus (nirsevimab-alip) for the prevention of...
